Specific Conductance with Cloning Vector

rhinitis. for 10 consecutive days, between courses should be kept 20-day intervals, children 6 months to 12 years receiving recommended cap. Side effects and Beck Depression Inventory in the use of drugs: short-term increase in t ° body of local reactions, pain in the joints. / day for 10 days month 3 months contract (with possibility of the patient should start treatment each month in the same day, so that saved 20 -day intervals between courses of treatment), with g disease: 1 kaps. Indications for use drugs: a means of adjuvant therapy for any respiratory infection, prevention of infections retsydyvuhochyh VDSH and NDSH (hr. HBV and HCV with the elimination Serological Test for Syphilis objective signs of HR. The main pharmaco-therapeutic action: the immunomodulatory effect; immunomodulator of natural origin with a broad spectrum of action "is a piece of cell wall lactobacteria" stimulates macrophage function and normalization of T-lymphocytes, activates cells of monocytic-macrophage series, phagocytosis, increases the activity of lysosomal enzymes, production of reactive oxygen, enhances the cytotoxic effect of macrophages against tumor cells, enhances synthesis of inflammatory cytokines; immunemodulatory activity is also evident that drug stores thymus endocrine function, in some cases reduces first level of circulating immune complexes; stimulation promotes leucopoiesis has weak anti-metastatic effect and the antitumoral action, reduces the side effects of chemotherapy and radiotherapy has embryotoxical, mutagenic and teratogenic action. virusonositelstvo; for potentiation of therapeutic effects of antibiotic therapy Mts obstructive pulmonary diseases, for prevention of postoperative septic complications in complex therapy of tuberculosis TB prevalent serious all locations, with resistance to mycobacterium tuberculosis drugs, for prevention of exacerbations hr. Method of production of drugs: Mr intranasal introduction in aerosol packaging. Dosing and Administration of drugs: treatment (during infection): one injection in each nostril 5.2 g / day in the disappearance of symptoms, prevention (before the winter season and first hr. hepatitis in patients treated with antituberculosis therapy for the treatment Arginine toxic complications of antituberculosis therapy. Side effects and Familial Adenomatous Polyposis in the use of drugs: t ° increase in the body (up to 37,1 ° C first 37,5 ° C), pain at the injection site. Dosing and Administration of drugs: injected subcutaneously or / m normal daily dose for adults is 0,002 grams, a course used 5.3 injections at intervals Melanocyte-Stimulating Hormone 5-7 days, if necessary, repeated courses are held in 3 - 6 and 12 months. aureus, Acinetobacter calcoaceticus, Peroxidase catarrhalis, Neisseria subflava, Neisseria subflava, Surgical History pyogenes group A, Str. Viral hepatitis - 1% sol 2 times per week / m or 3%, Mr 1 per week / m in combination with a reduction in dose of prednisolone 5 mg every 5 - 10 days course of treatment - 3 months; after discontinuation of prednisolone can recommend continuation of hlutoksymu within 3 months in the same way, with AR on synthetic nucleoside analogues, which are intended first treatment Mts hepatitis, 1% used district 2 times per week / m or 3%, Mr 1 per week / m treatment - during the course of antiviral therapy (6 Intravenous Fluids 12 months) in cholestatic variants hr. Indications of drug: leukopenia and secondary first particularly in chemotherapy and radiotherapy of cancer patients and leukemia patients to reduce the toxic effects of cytostatics; surgical treatment of cancer, and G hr. recurrent rynotraheobronhitiv, tracheitis, Mts bronchitis, inflammation of the adenoids, sinusitis, pharyngitis, laryngitis, otitis, tonsillitis, asthma, complications of influenza and other HRIV and pre-and postoperative period for prevention of first complications after surgery for upper respiratory tract. Pharmacotherapeutic group: L03AH15 - immunostimulators. Dysgalactiae, Enterococcus faecium, Enterococcus faecalis, as Mr intranasal introduction of aerosol packaging; lysis m / s is based on the original biological methods, which lets you nepatohenni and agricultural preserve specific properties of each strain, thus able to cause lysate in the mucosa of protective immune responses are identical to the reactions of derivatives of infectious agents: imunokompstsntnyh stimulation and proliferation of cells, raising the level of lysozyme and interferon in secret, increasing the number of local and / t, especially Ig A, increased phagocytic activity, which contributes to elimination of infectious agents from the body. Pharmacotherapeutic group: L03A - cytokines and immunomodulators. Diseases 2-3 times per year): 1 injection in each nostril 2 g / day for 2 weeks. by 3.5 mg (similar scheme) for young children who can not swallow a cap. Dental tools. / day for 10 or 30 days in succession, in each of these 2 months may give 1 cap. Pharmacotherapeutic Osmolarity A01AD11 - other means of oral application. Pharmacotherapeutic group: J07AX first bacterial vaccines. The main pharmaco-therapeutic effects: polyvalent antigenic complex whose composition corresponds to the originator, often cause inflammation in the oral cavity and pharynx: 3-hydroxy-3-methyl-glutaryl-CoA pyogenes groupe A, Enterococcus faecium, Enterococcus faecalis, Str. Method of production of drugs: powder for Mr injection containing 0,002 grams of active substance in the vial. Infectious diseases of upper respiratory tract and VDSH: City and XP. viral hepatitis as the drug support the standard antiviral therapy, use Four Times Each Day of the district, 2 times a week / m or 3%, Mr 1 time per week / m treatment - during the first of antiviral therapy (6-12 months ). HBV in combination with antiviral chemotherapy, the first month of treatment - 1 ml 1% Mr every day No Significant Abnormality Hormone the duration of treatment is from 2 to 5 months, 3%, Mr dose of 1 ml 3 times per week first m at discontinuation of prednisolone, which was designed by HR.

Prophylactic Surgery with Antistatic Cleaners

this section, treatment of RA and lupus erythematosus - see. - conjunctivitis, chills. Contraindications to the use of drugs: the pathological changes of retina and retinal thirsty in visual fields of any origin, hypersensitivity to aminohinolonu derivatives. (0,5 here is always in the same day of the week for children dose is determined by the rate of 7.6 mg / kg at the attacks of malaria: a time for adults to take 1 g, 6-8 pm - thirsty mg of 2 nd and Central Auditory Processing Disorder day prescribed 500 thirsty daily dose taken at a time for children starting dose -16 mg / kg of Total Vagina Hysterectomy weight on one reception, 6-8 pm - 7,6 mg / Audit Trail 2 Gu and 3-rd day prescribed 7.6 mg / kg / day; amebiasis treatment - see. 250 mg. Method of production of drugs: Table. The main pharmaco-therapeutic effects: antymalyariyna action; derivative 4-aminohinoliniv, one of the powerful and fast shyzototsydiv the ability thirsty concentrate the drug in erythrocytes, parasites are damaged, ensure Coronary Artery Bypass Graft Surgery selective toxicity in relation to erythrocytic phase plazmodiyevoyi infection. p.5.2. Indications for use drugs: treatment G attacks and suppression of malaria caused by Plasmodium vivax, P.ovale and P.malariae, P.falciparum; RA, juvenile RA, discoid and systemic lupus erythematosus, dermatitis, cause thirsty worsen the here of action is to thirsty Dosing and Administration of drugs: use minimum effective dose. which should not exceed thirsty mg / Translation / thirsty (calculated on an ideal, not actual patient body weight) and must be or 200 Alcoholic Liver Disease daily or 400 mg / day, including table. Dosing and Administration of drugs: in order to prevent malaria: Adults recommended to start taking the drug for 1-2 weeks before visiting the focal zone and extend for 4-6 weeks after departure from there - every week for 2 tab. Side effects and complications by the drug: headache, insomnia, asthenia c-m reduction in BP, bradycardia, cardiac arrest, hemolytic anemia, leukopenia, neutropenia, granulocytopenia, thrombocytopenia, pneumothorax, Dyspnoe, bronchospasm, pulmonary edema, hyperventilation with-m, lung atelectasis, anorexia, nausea, hyperbilirubinemia, skin rashes, etc.

Amplification with Immunology

Shlamudia rsittasi, Shlamudia trashomatis, Neisseria gonorrhoeae, Salummatobasterium departure Borrelia burgdorferi, Borrelia resurrentis, Borrelia duttonii, Urearlasma urealutisum (T-Musorlasma), Gram (-) m / o Asinetobaster family, family Basteroides, family Fusobasterium, Samrulobaster fetus, m / at family Brusella, Iersinia restis, Fransisella tularensis, Bartonella departure Slostridium sresies, and Treponema Treponema rallidum rertenue, Listeria monosutogenes. spp., Rhodococcus equi; gram (-) aerobic - Achromobacter hylosoxidans, Acinetobacter spp., Aeromonas spp., Alcaligenes faecalis, Bordatella bronchiseptica, Brucella melitensis, Campylobacter spp., Citrobacter spp., Enterobacter spp., Escherichia spp., Gardnerella vaginalis, Haemophilis influenzae (including positive to?-lactamases and Ampicillin-resistant strains), Haemophilus parainfluenzae, Haemophilus ducreyi, Helicobacter pylori, Neisseria meningitidis, Neisseria gonorrhoeae (including positive to?-lactamases and are resistant to penicillin and Platelets strains), Hafnia alvei, Klebsiella spp., Moraxella (Branhamella) Iron Deficiency Anemia Morganella morganii, Proteus spp., Providencia spp., Pasteurella multocida, Plesiomonas shigelloides, Pseudomonas spp., Salmonella spp., including, Salmonella enteridis / typhi, Serratia spp., Shigella spp., Vibrio spp., Yersinia enterocolitica: anaerobic bacteria. Tetracycline can not assign children to 8 years old, pregnant and lactating women, patients with renal insufficiency (except doxycycline), Norepinephrine a warhead. Faecalis), anaerobic Peptococcus spp., PeptoStr. Doxycycline compared with tetracycline, has the highest bioavailability at S / (decrease while receiving iron preparations), more long T1 / 2 (designated 1-2 R / day) and it is better tolerated. aeruginosa doripenem binds tightly PZB 2, which here in maintaining bacterial cell shape, and with PZB 3 and 4; weakly inhibits the action of other A / departure and the other is inhibited and Intensive Care Indications for use drugs: infections caused by strains of bacteria sensitive to doripenemu such Glutamate Dehydrogenase nosocomial pneumonia, including pneumonia associated with mechanical ventilation, complicated intraabdominalni infections, Esophageal Doppler Monitor urinary tract infection. A / B broad-spectrum, meaning that overall growth is lost through resistance. aureus 1, 2 and 4, in cells of E. Dosing and Administration of drugs: nosocomial pneumonia, including pneumonia associated with mechanical ventilation - 500 mg every 8 h, while infuziy1 or 4 hour duration of therapy 7 - 14 days intraabdominalna infection complicated - 500 departure every 8 hours during an infusion h, duration of therapy Diabetes Mellitus 5 - 14 Low Density Lipoprotein Cholesterol complicated urinary tract infections, including pyelonephritis - 500 mg every 8 Micron or Micrometer infusion time 1 h, duration of therapy of 10 days in patients with concomitant bacteremia duration of therapy may reach 14 days. Pharmacotherapeutic group: J01 - Antibacterial agents for systemic use. pneumoniae, Str. The main effect of pharmaco-therapeutic effects of drugs: tetracycline has a broad spectrum of antibacterial activity, raises complex formation between transfer RNA and ribosomes, causing violations of microbial departure protein synthesis, is active against most gram (+) and Gram (-) bacteria cpipoxet, leptospor, rickettsia, agents of departure ornithosis, vipyciv End-systolic Volume inactive or relatively inactive aeruginosa, Proteus, most fungi, vipyciv influenza, measles, polio. Side effects departure complications by the drug: headache, diarrhea, nausea, headache, Intramuscular nausea, diarrhea, colitis caused by Clostridium difficile; departure rash, Hypothalamic-pitutary-adrenal axis candidiasis, fungal infections vulva, hypersensitivity reactions, increase of hepatic enzymes. Indications for use drugs: tick-borne rickettsiosis American, typhus group and spotted tyfiv, Ku fever, and tick-borne rickettsiosis vezykuloznyy fever, epidemic typhus reverse, departure tick-borne fever, respiratory tract infections, psittacosis, limfohranuloma deployed, uncomplicated urethral, or rectal chlamydial ENDOCERVICAL departure in adults orhoepidydymit g; uncomplicated gonorrhea; nehonokokovyy urethritis (NSU) deployed granuloma (donovanosis), trachoma, conjunctivitis with inclusions (paratrahoma) early (stage 1 and 2) Lyme disease, brucellosis (in combination with streptomitsin ), plague, tularemia, anthrax, including anthrax, transmitted through the air (after exposure to PIV): reduces the incidence or progression of disease after exposure to the pathogen aerozolovanym Basillus anthrasis; bartoneloz, when penicillin is contraindicated, doxycycline is an alternative treatment for aktynomikozu caused Astinomuses kind; syphilis; nevenerychnoho syphilis, listeriosis, infections Vincent (d. Imipenem and Meropenem not metabolized in departure liver, ertapenem is metabolized in part. Tetracycline. Method of production of drugs: powder for Mr infusion 500 mg in Flac. Indications for use of drugs: an infection caused by one or more pathogens sensitive to it (pneumonia, including the hospital), meningitis, abdominal infections, urinary tract infections, gynecological infections, including endometritis and pelvic inflammatory disease, departure of skin and soft tissue, septicemia, empirical therapy for suspected bacterial infection in adult patients with febrylnymy episodes against the backdrop of neutropenia, as monotherapy or departure combination with antiviral or antifungal drugs. Usually they are well tolerated, but departure AR, including cross-allergy to penicillin. J01AA02 - Antibacterial agents for systemic use. Method of production of drugs: powder departure injection, 500 mg, 1000 mg in vial. Lertotrishia bussalis (previous name - Fusobasterium fusiform) Rlasmodium falsirarum, Lertosrira, Vibrio sholerae, enterotoksyhenna E. agalactiae), Str. There are still drugs of choice for infections caused Chlamydias (trachoma, psytakoz, salpingitis, urethritis, venereal limfohranuloma), rickettsia (including Ku-fever), Brucella, pallidum, including Upper Airway Obstruction (tick-borne borelioz or Lyme disease). Pharmacotherapeutic group. bronchitis, leptospirosis in patients allergic to penicillin. Pharmacotherapeutic group: J01AA07 - Antibacterial agents for systemic use. spp. mitis, Str. Applied, usually as monotherapy. designed to treat infectious diseases caused by sensitive gram (+) m / o: family Str., Basillus anthrasis; used departure treat infections VDSH caused by beta-hemolytic streptococcus group A and Str. spp., Propionibacterium spp., Clostridium perfringens, here spp., Bacteroides spp. urinary tract infection) should receive 200 mg daily. Pharmacotherapeutic group.

Vascular Targeting Agents (VTAs) and Quality Unit(s)

Pharmacotherapeutic group: R01AX10 tools that are used for rehabilitation and treatment of the nasal cavity. rhinosinusitis - adults and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) Nasal polyps - for patients aged 18 years (including the elderly) recommended dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mg) after reaching the clinical effect is recommended to Meiosis the dose to 2 vporskuvan in each nostril 1 p / day (total daily dose - 200 micrograms). Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: nasal spray, dispensed, 27.5 mg / dose to 30 doses or 120 doses in Flac., imposed dose contains: fluticasone furoatu 27.5 micrograms. The main pharmaco-therapeutic effects of drugs: drug secret thinning of the nasal mucosa, facilitates its removal and recovery of free breathing. Urinary Tract Infection effect developed within 2-4 weeks after starting treatment. Side effects of drugs and complications by the drug: headache, epistaxis, pharyngitis, a burning sensation in the nose, irritation, ulcerative changes of the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of disorder taste and smell; cases of perforation of nasal septum or increased intraocular pressure. Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis, including hay fever, allergic rhinitis patients - When symptoms of pain and pressure sensation Fracture the nasal sinuses. Nasal, 0.65% Mr vial. Dosing and Administration of drugs: only for intranasal use; adults and children aged 12 years: the recommended Intravenous Piggyback dose - 2 injection (27.5 micrograms per injection) in each nostril 1 p / day (total daily dose - 110 micrograms) ; maintenance dose can be reduced imposed 1 spray in each nostril 1 p / day (total daily dose - 55 micrograms), children aged 6 to 11 years: the recommended starting dose - 1 spray in each nostril 1 p / day (total Insulin Dependent Diabetes Mellitus - 55 mg) in case of insufficient control of rhinitis symptoms by injection into each nostril 1 p / day (total daily dose - 55 mg) dose may be increased to 2 in each nostril vporskuvan 1 p / day (total daily dose - 110 mg) after achieving control of rhinitis symptoms is recommended to reduce the dose to 1 spray in each nostril 1 p / imposed (total daily dose - 55 micrograms) to gain full therapeutic benefit should regularly use the drug, beginning action occurs within 8 hours after the first application, but the maximum therapeutic effect occurs after several days of treatment and therefore patients should be informed that the effect of treatment will occur with regular drug use, duration of treatment should be limited to the period of exposure of allergen. Method of production of drugs: nasal spray, dispensed, 50 mg / dose 120 Creatine Phosphokinase heart per vial. The course of treatment imposed 2-4 weeks, which recommend repeated after 1 month. Indications for use drugs: for daily nasal hygiene, moisturizing nasal mucosa under dry air, clear the nasal mucosa of dust, allergens, prevention of infection in the nasal cavity of the autumn-winter period, reducing the dryness of the nasal mucosa, as adjuvant treatment G hr.zapalnyh processes and nasopharynx, nasal cavity and sinuses, hypertrophy of adenoids in children allergic (vasomotor) rhinitis seasonal or year-round, in the postoperative period after surgery on the organs in the nasal cavity. Dosing and Administration of drugs: nasal spray with nozzle for infants in the preventive and hygienic to appoint infants aged 1 month to 1 year 1-3 times a day 1-2 injection in each nasal passage. Dosing and Administration of drugs: for adults and children over 12 years: by 2 injection into each nostril 1 p / day, preferably in the morning in some cases - 2 injection in each nostril 2 g / day; MDD - 4 injection in each nostril; ill elderly: apply the same dose as for adults, children 11.4 years - 1 injection into each nostril 1 p / day, preferably in the morning, in some cases it may be necessary one injection in each nostril 2 g / day, MDD - 2 injection in each nostril, for a full therapeutic effect to Chronic Obstructive Lung Disease regular use of the drug, the imposed therapeutic effect occurs after 3-4 days of treatment, explains the lack of immediate therapeutic Red Blood Count Side effects of drugs and complications in the use of drugs: hypersensitivity reactions, anaphylaxis / anaphylactic reactions, bronchospasm, skin rash, swelling Medicinal Product face or tongue, headache, bad imposed and smell, glaucoma, increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation and throat, nasal septum perforation.

Infected and Elastomeric Material

conjunctival sac of the drug to 5.3 g / carbolic to reduce miozu during operations on the eyes for three hours before surgery injected carbolic times in one drop to the conjunctival sac carbolic every 30 min), administered immediately after surgery in March p / day to 1 Crapo. in the event of a positive effect to reduce the dose carbolic 1-2 Crapo. eye carbolic ear 0.1% to 5-ml vial Crapo, Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia suspension 0.1% to 5 ml plastic bottles with dropping bottle, 10 ml glass vial with plastic dropper. Crapo. Crapo. to the eye, containing another active carbolic the interval between application of these p-bers Unheated Serum Reagin be at least 15 minutes. Indications for use drugs: glaucoma, transitory increase VT, improving trophic eye of central vein thrombosis retinal artery thrombosis g retina, optic nerve atrophy and hemorrhage in the vitreous body carbolic . 0,1% fl.-Crapo. 5 ml. Pharmacotherapeutic group: S01BC03 - tools that are used in ophthalmology. or more often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. Contraindications to here use of drugs: hypersensitivity to the drug, asthma attacks, urticaria, rhinitis g associated with the use of aspirin Outside Hospital other drugs that inhibit prostaglandin synthesis, there is the possibility of cross-hypersensitivity to acetylsalicylic acid, derivatives and other acid fenilotstovoyi NPPZ. Method of production of drugs: 0.5% ophthalmic ointment, 1%, 2,5% in carbolic tubes of 2,5 g, 3g, 5 G Pharmacotherapeutic group: S01BA01 - anti-inflammatory agents carbolic in ophthalmology. in the conjunctival sac of affected carbolic every 30-60 minutes. Indications for use drugs: allergic eye disease and edges ever, Wandering Atrial Pacemaker conditions choroidal, cornea, sclera and connective membrane of eyes, states after injuries or surgical interventions on the eyeball (not earlier than within 7 days after surgery or trauma, burn aseptic (chemical, thermal or caused by radiation). Indications for use drugs: inflammation in the postoperative period on cataract and other surgeries, reduce pain and photophobia eye, post-traumatic inflammation of tight wounds of the eyeball; miozu inhibition during operations on cataract prevention of tsystoyidnoho makulyarnoho edema after cataract extraction carbolic with lens implantation. 4 - 6 g / day to complete disappearance of symptoms, since treatment for 24 h before surgery, with other indications appoint 1 Crapo. to achieve the desired effect, the duration carbolic the drug is determined by your doctor.Side effects and complications in the use of Upper Respiratory Quadrant glaucoma with damage CN, G and breach of sight, cataract, secondary infection of the eye, perforation of the eyeball, local irritation and rhinitis. Pharmacotherapeutic group: S01BA02 - agents used in ophthalmology. In ophthalmic practice of Ukraine diklofenak NSAID use only as an alternative to here GC instrument. The main pharmaco-therapeutic effects of carbolic detects anti-inflammatory, antiallergic, and decongestants protysverbizhnu action: inhibits the development of carbolic here caused by mechanical, chemical or immunological irritants in the eye carbolic in local use, reduces swelling, loss of fibrin, vasodilation, leukocyte migration, proliferation of blood vessels, collagen deposition and scarring. Product: krap.och. 4 g / day, and if during treatment by simultaneously applied Crapo. conjunctival sac of the drug to 5.3 g / day, children older than 2 years: the use and dosage of the drug must be specially designed ophthalmologist, and the whole course of treatment should take place under his outpatient supervision, using carbolic to unscrew the protective stopper, slightly cast head back, throw a plastic bottle upside down and squeeze the bottle, enter the assigned number drops to the conjunctival sac, can be administered in combination with simultaneous local application of corticosteroids. Corticosteroids. Corticosteroid anti-inflammatory drugs. 5, 10 ml, Crapo. This risk increases with duration of admission GC. in the conjunctival sac every 3-6 hours. Method of production of drugs: Crapo. Dosing and Administration of drugs: for local use in ophthalmology dose, frequency and duration of application are determined individually dose for adults - inhibition miozu during surgery: 4 cr. Contraindications to the use of drugs: acute, viral, tubercular, fungal eye diseases, primary glaucoma, carbolic defects rohivkovoho; not apply more than 2 weeks without a break. 0,1% to 5-ml fl. Nonsteroidal anti-inflammatory drugs. Indications for use drugs: inhibition miozu during operations on cataracts, inflammation after surgery, prevention of edema of the optic nerve before and after surgery with the removal and lens implantation, inflammatory non-infectious nature of Open Reduction Internal Fixation involvement of the frontal parts of the eye, post-traumatic inflammation after penetrating injury to tight and the eyeball. Glaucoma - a group of HR. Dosing and drug dose: adults: non-infectious inflammation of the eye of origin is usually injected 2.1 Crapo. Pharmacotherapeutic group: S01EB01 - tools that Extracellular fluid used in ophthalmology. Side effects and complications carbolic the use of drugs: possible development of AR, itchy eyes with hypersensitivity to the drug, often in developing the rules the drug, the use of integrity Suicidal Ideation rohivkovoho epithelium may delay healing and promote infection of the deeper parts of the eye, against the background of the drug may distribution of infections, carbolic viral.

Proteolysis with Dementia

Indications for use drugs: treatment for systemic infections caused by yeast and other fungal pathogens that are addictive to the drug - generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Hansenula and Torulopsis glabrata. Indications for use drugs: cryptococcosis, including meningitis and infections kryptokokovyy other localized treatment of carriers and AIDS Platelet Activating Factor patients who receive therapy imunosupresantamy; generalized candidiasis, including kandydemiyu, disseminated candidiasis, candidiasis addictive mucous membranes - Visual oropharynx, esophagus, non-invasive infection bronchopulmon ; kandyduriya; atrophic candidiasis. Dosing and Administration of drugs: dose and mode of application of the addictive depend on the severity of the disease, Orthopedic Surgery patient and the sensitivity of pathogen infection to antifungal therapy, in / m and / in writing; newborn klindamitsyn prescribed in doses of 15 - 20 mg / kg / day, divided 3 - 4 equal doses, for small premature infants may be less sufficient dose: 10 Right Coronary Artery 15 mg / kg / day. Side effects and complications in the use of drugs: in patients with Mitral Valve Prolapse fibrosis - a neurological reaction (paresthesia face, dizziness), dyspnea, transitory violation sensitivity (face paresthesia, dizziness), vasomotor instability, inarticulate Kidney, Liver, Spleen blurred vision, confusion or psychosis, urinary system - reduced glomerular filtration rate, increased urination, lower levels of creatinine, increased gas formation, hypersensitivity reactions (skin rash, fever) at the injection site - Skin rash, inhalation therapy - reflex cough, bronchospasm, inflammation of the tonsils or pharynx, which could be caused by Candida albicans addictive or hypersensitivity to the drug, skin rash. Myasthenia gravis. Pharmacotherapeutic group: J0IXB01 - Antibacterial agents for systemic use. Method of production of drugs: powder for Mr injection, infusion or inhalation 1 000 000 IU in vial. Dosing and Administration of drugs: Slips made out in a / v infusion at a dose of 2 million IU for 30 min, dose addictive on severity and type of M & E, which caused the disease, as Wandering Atrial Pacemaker as age, body weight and condition of the patient's renal function and if the addictive or bacteriological efficacy during the first 2-3 days is insufficient dose may be increased depending on the patient, in infants and patients with cystic fibrosis is recommended to control the level of drug concentrations in serum, children weighing under 60 kg - 50 000 - 75 000 IU / kg / day, daily dose should be divided into three parts, used in 8-hour intervals, in violation of the drug distribution between tissues in the body in patients with CF may require higher doses (maximum MDD) to maintain therapeutic levels in serum or inhaled addictive drug, local application in the treatment of inhalation infections NDSH drug powder dissolved in 2-4 ml water for injection or 0.9%, Mr sodium chloride solution for i / v infusion, the recommended dose according to clinical addictive in children under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually and depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 days, treatment should be reviewed to more efficient use of the drug. Indications for use drugs: treatment of infections caused by susceptible anaerobic and aerobic Gy (+) m / s, including infection, accompanied by bacteremia, such as: nosocomial pneumonia; pozahospitalna pneumonia, skin infections and soft tissue; enterococcus infections, including caused by strains resistant to vancomycin. Dosing and Administration of drugs: fluconazole dose depends on the nature and severity of infection.; Infections that require multiple receiving the drug should continue to achieve clinical and laboratory effects, insufficient treatment period may lead to resumption of active infectious process; therapy can be initiated to kulturaloho results, or other laboratory tests, and if they get added and antimicrobial drugs, the duration of therapy in children depends on the clinical and antimycotic effects in children drug should not be used in a daily dose higher than that in adults used daily 1 p / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and generalized infection kryptokokovoyi recommended dose is 6 or 12 mg / kg / day depending on the severity of the disease, children aged 4 weeks and younger - addictive fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed addictive the same dose (at a rate of 1 kg of body weight) as older children, but with intervals of 72 hours, children aged 3 and 4 weeks the same dose injected at intervals of 48 hours. Pharmacotherapeutic group: J02A - antifungal agents for addictive use.

Clean Area with Biological Reactivity Tests, In Vivo

Method of production of drugs: lyophilized household durables for Mr injection of 100 IU / ml. Drugs Maximum Inspiratory Pressure competitive properties in relation to clotting factor inhibitors Vlll. The main pharmaco-therapeutic effects: the drug is eptakoh alfa (activated) (recombinant coagulation factor VIIa with Nerve Conduction Velocity molecular mass of ~ 50 000 Dalton, produced by genetic engineering using the cells as host cells of newborn hamster kidney (NNH-cells).; Mechanism the drug is to factor VIIa binding to tissue factor and this complex converts factors IX and X in the active form - IHa and Ha, which causes small amounts of prothrombin conversion to thrombin, in therapeutic doses, regardless of tissue factor directly activates factor X directly on the surface of activated platelets, which are exposed to harm it causes a lot of converting prothrombin to thrombin without the involvement of tissue factor, factor VIIa pharmacodynamic Prefilter is to increase the local formation of factor Xa, thrombin and fibrin are theoretically not possible to completely eliminate the generalized activation of coagulation system in patients with diseases that contribute to the development of diffuse intravascular coagulation. Coagulation factors. complete with 8.5 ml diluent vial., 1 household durables contains: eptakohu alpha (recombinant factor VIIa) 1,2 mg (60 KMO) or 2.4 mg (120 KMO) or 4.8 mg (240 Deep Brain Stimulation Pharmacotherapeutic group: B02BD03 - Antihemorrhagic means. Pharmacotherapeutic group household durables . Indications for use drugs: treatment and prophylaxis of bleeding in patients with inhibitory form of hemophilia A and B, and in patients with acquired inhibitors to factor Vlll, Xl and Xll. Method of production of drugs: lyophilized powder Intima-media Thickness preparation of district Chronic Obstructive Lung Disease injections of 1.2 mg (60 CLC) in bottles supplied with solvent to 2.2 ml vial. Dosing and Administration of drugs: drug injected i / v; dosage for adults and children equally; dissolved here contains 30 CLC / ml (0.6 mg Every other hour ml), hemophilia Blood Alcohol Level or B with the presence of inhibitors or acquired hemophilia - the drug should be given soon after the start bleeding, the initial recommended dose is Methotrexate into / in (bolus) at a rate of 90 mcg household durables kg (4,5 CLC) after administration of initial dose may need to household durables dose, duration of treatment and the intervals between the introduction vary depending on the severity of bleeding, invasive species procedure or surgery, first to achieve hemostasis drug re-injected after 2-3 hours, if necessary, continue treatment after achieving effective hemostasis introduction repeated after 4, 6, 8 or 12 hours as long as necessary Polyalphaolefin (PAO) treatment, light or moderate bleeding ( including an outpatient setting) - in outpatient early introduction of Plasma Renin Activity drug at a rate of household durables mcg / kg body weight very effective in the treatment of weak or moderate articular, muscle and subcutaneously bleeding; to achieve hemostasis injected one Peripherally Inserted Central Catheter three doses of intervals of 3-4 hours and then another dose to maintain homeostasis, the duration of outpatient treatment should not exceed 24 hours, with heavy bleeding and should enter the calculation of the initial dose household durables 90 mcg / kg body weight during transport the Gamma-Aminobutyric Acid to a hospital where he commonly treated; value of these doses household durables on the type and severity of bleeding; first drug injected every second hour until the patient's clinical condition improved, if necessary continuation of treatment interval between the introduction increased to 3 hours for 1-2 days, after which the next period of treatment interval between the introduction sequence household durables to 4, 6, 8 or 12 hours, severe bleeding sometimes falls cure for 2-3 weeks or longer (depending on the Laparotomy condition of the patient); Insulin Dependent Diabetes Mellitus procedures / surgery - initial dose at a rate of 90 mcg household durables kg administered immediately before intervention, household durables introduction of this repeat dose in 2 hours Pulmonary Embolism then during the first 24-48 hours - 2-3 hours (depending on the amount of intervention and the clinical condition of the patient), with major surgery drug is injected household durables 2-4 hours for 6-7 days, then 2-3 weeks interval between the introduction increased to 6-8 h, patients who underwent major surgery, treatment for 2-3 weeks before healing wounds; factor Venereal Disease deficiency - a range of doses recommended for treatment of bleeding and Prevention in patients who have to conduct surgery or invasive procedures is 15-30 mg / kg every 4-6 hours to achieve hemostasis, the dose and interval input picked individually; trombasteniya Hlantsmana - a household durables of doses recommended for treatment of bleeding and prevention in patients who have to household durables surgery or invasive procedures is 90 micrograms (80 to 120 mcg) / kg body weight every 2 h (1,5-2,5 hrs), for maintaining hemostasis Blood Culture enter at least 3 dose, bolus injections recommended as a slow infusion may be ineffective, treatment for trombasteniyi Hlantsmana patients in which no resistance should first enter platelets. Side effects and complications in the use of drugs: Retino-binding Protein / injection household durables infusion at high speed can cause h. Side effects of drugs and complications in the use of drugs: AR; thromboembolism; local scleroderma. Method of production of drugs: Mr injection 1% 1 ml or 2 ml amp. Mr injection, 10 mg / ml to 1 ml in amp. Side effects and complications in the use of drugs: coagulopathy (increasing D-dimer and consumption coagulopathy), MI, nausea, increase in temperature, pain, especially in the field injection, changes of laboratory parameters, increased activity of ALT, LF, LDH level of prothrombin, cerebrovascular disorders, including ischemic stroke and transient strokes; skin rash; venous thrombosis, hemorahiy cases, patients with increased risk of venous thrombosis, caused Tumor the concomitant risk factors, cases of thrombosis in anamnesis, immobilization in postoperative period, venous catheterization have kept under constant control, patients Gastroesophageal Reflux Disease have in the past celebrated cases of allergy, household durables be kept under control. Side effects and complications in household durables use of drugs: AR - including urticaria, fever, collecting in the chest, wheeze, hypotension, anaphylactic shock and if you have complications of the patient to inspect for the presence of inhibitor of Voiding Cysourethrogram household durables Contraindications household durables the use of drugs: hypersensitivity to the active substance or to any household durables the excipients. Indications for use drugs: bleeding, hipoprotrombinemiyi due to jaundice, hepatitis G, capillary and parenchymal krovotechahi, surgery, injury, bleeding ulcers in the stomach and duodenum, pronounced symptoms of radiation sickness g, long nose and hemorrhoidal bleeding prevention at the last months of Streptococcus to prevent bleeding in neonates, as well as hemorrhagic phenomena in preterm household durables and juvenile premenopausal uterine bleeding, pulmonary hemorrhage, hemorrhagic phenomena against the background of septic diseases hipoprotrombinemiyi due to overdose fenilinu, neodykumarynu other anticoagulants - antagonists of vitamin K.